- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06152081
Caries Detection With Two Different Caries Detecting Devices
August 4, 2025 updated by: Tufts University
A Pilot Clinical Trial Comparing the Efficacy of Caries Detection With a Novel Caries Detecting Rinse and Existing Diagnostic Tools
The primary aim of this study will be to compare the effectiveness of the novel LumiCare™ rinse and with QLF in determining caries progression.
The secondary aim is to compare the progression of carious lesions between patients who reported use of e-cigarettes/vapes and those who did not.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Karina Irusa, BDS,MS
- Phone Number: 6176362408
- Email: dentalresearchadministration@tufts.edu
Study Contact Backup
- Name: Ann-Marie Billig
- Phone Number: 6176363931
- Email: dentalresearchadministration@tufts.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Recruiting
- Tufts University School of Dental Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients of TUSDM Comprehensive Care Clinic
- Adult patients over the age of 21
- Extreme/High Caries Risk classification per TUSDM Caries Management by Risk Assessment (CAMBRA) form
- Presence of 2 or more initial active primary carious lesions on a free coronal surface of any tooth by visual assessment, QLF, and LumiCare™
- Presence of at least 1 cavitated lesion
- Updated (no more than 6 months old) bite wing radiographs available.
- Patients who responded either yes/no to use of e-cigarettes/vapes
- 1 active caries, 1 inactive caries and 1 sound tooth surface.
Exclusion Criteria:
- Low or moderate caries risk classification per TUSDM CAMBRA form
- No clinically detectable carious lesions on free coronal surfaces
- No cavitated caries lesions
- Carious teeth with caries lesions concomitant with extrinsic stains, fluorosis, or developmental defects.
- Patients who responded yes to the use of conventional cigarettes or smokeless tobacco
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: All Participants
All participants enrolled in the study will have the two caries detecting devices used during each research visit.
|
The teeth being assessed will be cleaned of any debris ,plaque and calculus.
The areas being assessed will be air dried.
A dry field will be maintained using cotton rolls and a saliva ejector.
Lumicare rinse will be applied onto the test areas for 30 seconds and the excess removed using a saliva ejector.
The sites will then be rinsed with plain water for 10 seconds and excess will be removed using high volume suction.
A blue curing light will then be held 1-2 inches from the test surfaces while the examiner assesses the surfaces for the presence or absence of fluorescent illumination.
The teeth being assessed will be cleaned of any debris ,plaque and calculus.
The areas being assessed will be air dried.
A dry field will be maintained using cotton rolls and a saliva ejector.
The QLF device will be positioned over the tooth surface to be tested and an image will be taken.
The images will be stored automatically and assessed by the examiners for the presence of green fluorescence using the QA2 program (Version 1.25, Inspektor Research systems BV, Amsterdam, The Netherlands) .
The trend in green fluorescence will also be calculated using this software algorithm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of two caries-detecting devices
Time Frame: 12 months
|
Compare the effectiveness of the two caries detecting devices in their ability determining caries progression
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caries progression in those who do and do not use e-cigarettes/vapes
Time Frame: 12 months
|
Comparison of the progression of carious lesions between patients who reported use of e-cigarettes/vapes and those who did not
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Karina Irusa, BDS, MS, Tufts University School of Dental Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2025
Primary Completion (Estimated)
April 1, 2026
Study Completion (Estimated)
October 1, 2027
Study Registration Dates
First Submitted
June 13, 2023
First Submitted That Met QC Criteria
November 21, 2023
First Posted (Actual)
November 30, 2023
Study Record Updates
Last Update Posted (Actual)
August 5, 2025
Last Update Submitted That Met QC Criteria
August 4, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003913
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caries,Dental
-
National University of San Marcos, PeruNot yet recruitingPit and Fissure Caries | Caries,Dental | Sealant DentalPeru
-
Ain Shams UniversityCompletedPulpitis | Caries | Caries,Dental | Reversible Pulpitis | Caries Class I | Caries; DentinEgypt
-
University of MinnesotaCompletedUsing Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood CariesCaries | Caries,DentalUnited States
-
Future University in EgyptNot yet recruitingDeep Caries | Caries, Dental
-
Federal University of PelotasRecruiting
-
Kompetansesenteret Tannhelse Midt (TkMidt)Karolinska Institutet; University of Bergen; Norwegian University of Science... and other collaboratorsActive, not recruiting
-
Marmara UniversityCompleted
-
Suez Canal UniversityCompleted
-
Pomeranian Medical University SzczecinCompleted
-
Rawda Hesham Abd ElAzizRecruitingCaries,Dental | Caries Class IIEgypt
Clinical Trials on LumiCare rinse
-
Biomedical Development CorporationBaylor College of Medicine; National Institute of Diabetes and Digestive and...CompletedCystitis | Urinary Tract InfectionsUnited States
-
Swansea UniversityUniversity Hospital of WalesCompleted
-
Biomedical Development CorporationMethodist Healthcare Ministries of South Texas; Foundation Of Collaborative...CompletedPeriodontitis | Diabetes Type 2United States
-
Sunstar AmericasCompleted
-
Biomedical Development CorporationNational Heart, Lung, and Blood Institute (NHLBI); University of KentuckyUnknownGingivitis | Investigation of Biological Markers of InflammationUnited States
-
ParaPRO LLCCompleted
-
Ain Shams UniversityCompletedRecurrent Aphthous StomatitisEgypt
-
Malmö UniversityNovozymes A/SActive, not recruiting
-
ParaPRO LLCCompleted
-
Rowpar Pharmaceuticals, Inc.University Health Resources GroupCompletedOral Malodor